Qu and colleagues also analyzed SMA phenotype, serum phosphorus, alkaline phosphatase, and 25-Hydroxyvitamin D levels, but ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic ...

a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) produced under cGMP conditions and intended to treat both local GI and systemic diseases. For more information, ...

Further, our Phase 3 IDELA trial is ongoing and offers us an opportunity to understand the effect of Seladelpar in normalizing alkaline phosphatase in a broader set of PBC patients who had an ...